De Escalation Eligibility

De-escalation Eligibility: IV-to-oral and spectrum de-escalation checklist after early response to therapy.

Clinical Factors

Assessment Tier

Not Ready

Score 0

Complex infection features argue against early de-escalation.

Guidelines & Evidence

Clinical Details

Section 1

When to Use

Use during early bedside triage when infection severity or treatment escalation is uncertain.

Support clinician judgement with a structured review of the highest-yield risk factors.

Standardise communication between admitting, ID, ICU, and pharmacy teams.

Section 2

Formula & Logic

Scoring Logic

Afebrile / improving hemodynamics (+2)

Able to absorb oral medication (+2)

Source controlled (+1)

Cultures allow narrower therapy (+1)

Endocarditis / CNS / deep infection (-3)

Severe immunocompromise (-1)

Section 3

Next Steps

Clinical Actions

Interpret the result together with source control, microbiology, host factors, and trajectory.

Escalate imaging, cultures, or specialist review when the tool lands in a high-risk tier.

Reassess dynamically if the patient deteriorates or new microbiology becomes available.

Section 4

Pearls/Pitfalls

Important Caveat

This tool supports structured infectious-disease decision making but does not replace clinician judgement or local guideline pathways.

Section 5

Evidence Appraisal

Evidence Base

This OpiCalc infectious-disease entry reflects commonly used guideline criteria and bedside risk features used in contemporary clinical practice.

Last Comprehensive Review: 2026

Related Infectious Disease Tools

Antibiotic Duration Guide

Antibiotic PKPD Optimisation

APACHE II Sepsis Context

ATS IDSA CAP Severity

Bacteremia Risk Shapiro

Bacterial Meningitis Score

C difficile Severity Recurrence

CAUTI Criteria

CD4 OI Risk

Centor Criteria

Have feedback about this calculator?Let us know.